Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

Eli Lilly total long term liabilities for the quarter ending September 30, 2024 were $36.612B, a 48.77% increase year-over-year.

  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.
  • Eli Lilly total long term liabilities for 2021 were $24.599B, a 13.16% decline from 2020.

Eli Lilly Total Long Term Liabilities 2010-2024 | LLY

  • Eli Lilly total long term liabilities for 2023 were $25.849B, a 19.81% increase from 2022.
  • Eli Lilly total long term liabilities for 2022 were $21.576B, a 12.29% decline from 2021.
  • Eli Lilly total long term liabilities for 2021 were $24.599B, a 13.16% decline from 2020.
Related Stocks
Company NameMarket
Cap
Novo Nordisk (NVO)$481.1B
Johnson & Johnson (JNJ)$374.3B
AbbVie (ABBV)$352.5B
Merck (MRK)$260.4B
Novartis AG (NVS)$217.6B
AstraZeneca (AZN)$200B
Pfizer (PFE)$151.4B
Sanofi (SNY)$130.2B
Innoviva (INVA)$1.3B